Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
|
Expensive Performer
6125.5000
-74.50
(
-1.20
%)
NSE
Sep 22, 2025
11:33 AM
Volume:
79,825
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
10 Feb 2024
6125.50
-1.20%
Divi's Labs (SELL): Healthy margin recovery, heady valuations
Sell:
Divi's Laboratories Ltd.
by
BOB Capital Markets Ltd.
Target: 3000
Recommendation
Target
BOB Capital Markets Ltd.
Q3 revenue grew 9% YoY on 25% rise in custom synthesis business; API and nutraceuticals stayed soft
Divi's Laboratories Ltd.'s price crossed above 200Day SMA today
More from Divi's Laboratories Ltd.
Recommended
Market trades lower, Netweb Tech bags Rs 450 cr AI order
Trendlyne Marketwatch |
22 Sep 2025, 11:25AM
Five Interesting Stocks Today - September 19, 2025
The Baseline |
19 Sep 2025
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022